XENON PHARMACEUTICALS INC. Stock-Based Compensation
XENON PHARMACEUTICALS INC. (XENE) reported Stock-Based Compensation of $16.73 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- XENON PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $16.73M, a 22.02% increase year-over-year.
- XENON PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $16.89M, a 38.77% increase year-over-year.
- XENON PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $14.12M, a 3.79% increase year-over-year.
- XENON PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $13.71M, a 5.41% increase year-over-year.
- XENON PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2025 was $53.71M, a 5.90% increase from fiscal 2024.
- XENON PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2024 was $50.72M, a 56.67% increase from fiscal 2023.
- XENON PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2023 was $32.37M, a 58.87% increase from fiscal 2022.
- XENON PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2022 was $20.38M, a 103.41% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $16.73M 10-Q · filed 2026-08-06 | $33.63M 10-Q · filed 2026-08-06 | $47.74M derived: sum of 3 quarters · filed 2026-08-06 | $61.45M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $16.89M 10-Q · filed 2026-05-07 | $31.01M derived: sum of 2 quarters · filed 2026-05-07 | $44.71M derived: sum of 3 quarters · filed 2026-05-07 | $58.43M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $14.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $27.82M derived: sum of 2 quarters · filed 2026-02-26 | $41.53M derived: sum of 3 quarters · filed 2026-08-06 | $53.71M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $13.71M 10-Q · filed 2025-11-03 | $27.42M derived: sum of 2 quarters · filed 2026-08-06 | $39.59M 10-Q · filed 2025-11-03 | $53.19M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $13.71M 10-Q · filed 2026-08-06 | $25.89M 10-Q · filed 2026-08-06 | $39.49M derived: sum of 3 quarters · filed 2026-08-06 | $52.49M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $12.17M 10-Q · filed 2026-05-07 | $25.77M derived: sum of 2 quarters · filed 2026-05-07 | $38.77M derived: sum of 3 quarters · filed 2026-05-07 | $53.49M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $13.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $26.60M derived: sum of 2 quarters · filed 2026-02-26 | $41.32M derived: sum of 3 quarters · filed 2026-02-26 | $50.72M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $13.00M 10-Q · filed 2025-11-03 | $27.72M derived: sum of 2 quarters · filed 2025-11-03 | $37.12M 10-Q · filed 2025-11-03 | $46.30M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $14.72M 10-Q · filed 2025-08-11 | $24.12M 10-Q · filed 2025-08-11 | $33.30M derived: sum of 3 quarters · filed 2026-02-26 | $42.04M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $9.40M 10-Q · filed 2025-05-12 | $18.58M derived: sum of 2 quarters · filed 2026-02-26 | $27.32M derived: sum of 3 quarters · filed 2026-02-26 | $35.78M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $9.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $17.93M derived: sum of 2 quarters · filed 2026-02-26 | $26.38M derived: sum of 3 quarters · filed 2026-02-26 | $32.37M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $8.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $17.20M derived: sum of 2 quarters · filed 2024-11-12 | $23.19M 10-Q · filed 2024-11-12 | $29.00M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $8.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $14.45M 10-Q · filed 2024-08-08 | $20.26M derived: sum of 3 quarters · filed 2025-02-27 | $26.00M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $5.99M 10-Q · filed 2024-05-09 | $11.81M derived: sum of 2 quarters · filed 2025-02-27 | $17.55M derived: sum of 3 quarters · filed 2025-02-27 | $22.76M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $5.81M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $11.55M derived: sum of 2 quarters · filed 2025-02-27 | $16.76M derived: sum of 3 quarters · filed 2025-02-27 | $20.38M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $5.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $10.95M derived: sum of 2 quarters · filed 2023-11-08 | $14.56M 10-Q · filed 2023-11-08 | $17.27M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $5.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $8.82M 10-Q · filed 2023-08-09 | $11.53M derived: sum of 3 quarters · filed 2024-02-29 | $14.17M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | $3.61M 10-Q · filed 2023-05-09 | $6.32M derived: sum of 2 quarters · filed 2024-02-29 | $8.96M derived: sum of 3 quarters · filed 2024-02-29 | $11.67M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | $2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $5.35M derived: sum of 2 quarters · filed 2024-02-29 | $8.05M derived: sum of 3 quarters · filed 2024-02-29 | $10.02M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $2.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $5.35M derived: sum of 2 quarters · filed 2022-11-08 | $7.31M 10-Q · filed 2022-11-08 | $8.92M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | $2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $4.67M 10-Q · filed 2022-08-09 | $6.28M derived: sum of 3 quarters · filed 2023-03-01 | $7.86M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $1.97M 10-Q · filed 2022-05-10 | $3.58M derived: sum of 2 quarters · filed 2023-03-01 | $5.16M derived: sum of 3 quarters · filed 2023-03-01 | $6.63M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $3.19M derived: sum of 2 quarters · filed 2023-03-01 | $4.66M derived: sum of 3 quarters · filed 2023-03-01 | $5.68M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $3.05M derived: sum of 2 quarters · filed 2021-11-10 | $4.07M 10-Q · filed 2021-11-10 | $5.42M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $2.49M 10-Q · filed 2021-08-11 | $3.84M derived: sum of 3 quarters · filed 2021-08-11 | $4.46M derived: sum of 4 quarters · filed 2021-08-11 | |
| 2020-03-31 | $1.01M 10-Q · filed 2021-05-11 | $2.37M derived: sum of 2 quarters · filed 2021-05-11 | $2.98M derived: sum of 3 quarters · filed 2021-05-11 | $3.45M derived: sum of 4 quarters · filed 2021-05-11 | |
| 2019-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.97M derived: sum of 2 quarters · filed 2021-03-01 | $2.43M derived: sum of 3 quarters · filed 2021-03-01 | $2.92M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $612.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.08M derived: sum of 2 quarters · filed 2020-11-05 | $1.57M 10-Q · filed 2020-11-05 | $2.14M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | $464.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2020-08-06 | $955.00K 10-Q · filed 2020-08-06 | $1.53M derived: sum of 3 quarters · filed 2020-08-06 | $2.22M derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | $491.00K 10-Q/A · filed 2020-05-26 | $1.07M derived: sum of 2 quarters · filed 2020-05-26 | $1.75M derived: sum of 3 quarters · filed 2020-05-26 | $2.45M derived: sum of 4 quarters · filed 2020-05-26 | |
| 2018-12-31 | $575.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $1.26M derived: sum of 2 quarters · filed 2020-03-09 | $1.96M derived: sum of 3 quarters · filed 2020-03-09 | $2.63M 10-K · filed 2020-03-09 | |
| 2018-09-30 | $687.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $1.39M derived: sum of 2 quarters · filed 2019-11-05 | $2.05M 10-Q · filed 2019-11-05 | $2.64M derived: sum of 4 quarters · filed 2019-11-05 | |
| 2018-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $1.36M 10-Q · filed 2019-08-06 | $1.96M derived: sum of 3 quarters · filed 2019-08-06 | $2.52M derived: sum of 4 quarters · filed 2019-08-06 | |
| 2018-03-31 | $663.00K 10-Q · filed 2019-05-07 | $1.26M derived: sum of 2 quarters · filed 2019-05-07 | $1.82M derived: sum of 3 quarters · filed 2019-05-07 | $2.42M derived: sum of 4 quarters · filed 2019-05-07 | |
| 2017-12-31 | $593.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $1.16M derived: sum of 2 quarters · filed 2019-03-06 | $1.76M derived: sum of 3 quarters · filed 2019-03-06 | $2.24M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $567.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $1.17M derived: sum of 2 quarters · filed 2018-11-06 | $1.64M 10-Q · filed 2018-11-06 | $2.16M derived: sum of 4 quarters · filed 2018-11-06 | |
| 2017-06-30 | $598.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $1.08M 10-Q · filed 2018-08-07 | $1.59M derived: sum of 3 quarters · filed 2018-08-07 | $2.23M derived: sum of 4 quarters · filed 2018-08-07 | |
| 2017-03-31 | $478.00K 10-Q · filed 2018-05-08 | $997.00K derived: sum of 2 quarters · filed 2018-05-08 | $1.63M derived: sum of 3 quarters · filed 2018-05-08 | $2.05M derived: sum of 4 quarters · filed 2018-05-08 | |
| 2016-12-31 | $519.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $1.16M derived: sum of 2 quarters · filed 2018-03-07 | $1.57M derived: sum of 3 quarters · filed 2018-03-07 | $2.16M 10-K · filed 2018-03-07 | |
| 2016-09-30 | $636.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.05M derived: sum of 2 quarters · filed 2017-11-07 | $1.64M 10-Q · filed 2017-11-07 | $2.12M derived: sum of 4 quarters · filed 2018-03-07 | |
| 2016-06-30 | $414.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $1.01M 10-Q · filed 2017-08-03 | $1.48M derived: sum of 3 quarters · filed 2018-03-07 | $1.29M derived: sum of 4 quarters · filed 2018-03-07 | |
| 2016-03-31 | $592.00K 10-Q · filed 2017-05-09 | $1.07M derived: sum of 2 quarters · filed 2018-03-07 | $875.00K derived: sum of 3 quarters · filed 2018-03-07 | -$898.00K derived: sum of 4 quarters · filed 2018-03-07 | |
| 2015-12-31 | $474.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $283.00K derived: sum of 2 quarters · filed 2018-03-07 | -$1.49M derived: sum of 3 quarters · filed 2018-03-07 | $3.73M 10-K · filed 2018-03-07 | |
| 2015-09-30 | -$191.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$1.96M derived: sum of 2 quarters · filed 2016-11-03 | $3.25M 10-Q · filed 2016-11-03 | $3.45M derived: sum of 4 quarters · filed 2017-03-08 | |
| 2015-06-30 | -$1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $3.45M 10-Q · filed 2016-08-03 | $3.65M derived: sum of 3 quarters · filed 2017-03-08 | $3.83M derived: sum of 4 quarters · filed 2017-03-08 | |
| 2015-03-31 | $5.22M 10-Q · filed 2016-05-10 | $288.00K 10-Q · filed 2015-05-12 | $5.42M derived: sum of 2 quarters · filed 2017-03-08 | $5.61M derived: sum of 3 quarters · filed 2017-03-08 | $5.79M derived: sum of 4 quarters · filed 2017-03-08 |
| 2014-12-31 | $199.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $387.00K derived: sum of 2 quarters · filed 2017-03-08 | $574.00K derived: sum of 3 quarters · filed 2017-03-08 | $760.00K 10-K · filed 2017-03-08 | |
| 2014-09-30 | $188.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $375.00K derived: sum of 2 quarters · filed 2015-11-10 | $561.00K 10-Q · filed 2015-11-10 | $723.00K derived: sum of 4 quarters · filed 2016-03-08 | |
| 2014-06-30 | $187.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-08-13 | $373.00K 10-Q · filed 2015-08-13 | $535.00K derived: sum of 3 quarters · filed 2016-03-08 | ||
| 2014-03-31 | $186.00K 10-Q/A · filed 2015-08-13 | $348.00K derived: sum of 2 quarters · filed 2016-03-08 | |||
| 2013-12-31 | $162.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | $575.00K 10-K · filed 2016-03-08 | |||
| 2013-09-30 | $413.00K 10-Q · filed 2014-12-15 | ||||
| 2012-12-31 | $406.00K 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 |